EFNS guidelines on the diagnostic approach to pauci‐ or asymptomatic hyperCKemia
Open Access
- 13 May 2010
- journal article
- practice guideline
- Published by Wiley in European Journal of Neurology
- Vol. 17 (6) , 767-773
Abstract
Objective: To provide evidence‐based guidelines to general neurologists for the assessment of patients with pauci‐ or asymptomatic hyperCKemia.Background: Recent epidemiologic studies show that up to 20% of ‘normal’ individuals have an elevated creatine kinase activity in the serum (sCK). The possibility of a subclinical myopathy is often raised, and patients may be unnecessarily denied treatment with statins.Search strategy: Electronic databases including Medline, the Cochrane Library and the American Academy of Neurology were searched for existing guidelines. Articles dealing with series of patients investigated for asymptomatic/pauci‐symptomatic hyperCKemia and articles dealing with myopathies that can present with asymptomatic hyperCKemia were identified and reviewed.Results: The only guidelines found were those approved by the Italian Association of Myology Committee, and the only relevant articles identified describe class IV studies.Recommendations: HyperCKemia needs to be redefined as values beyond 1.5 times the upper limit of normal (which itself needs to be appropriately defined). Pauci‐ or asymptomatic hyperCKemia with no apparent medical explanation may be investigated with a muscle biopsy if one or more of the following are present; the sCK is ≥3× normal, the electromyogram is myopathic or the patient is <25 years of age. In addition, women with sCK<3 times normal may be offered DNA testing because of the possibility of carrying a dystrophin mutation.Keywords
This publication has 32 references indexed in Scilit:
- Effect of newly proposed CK reference limits on neuromuscular diagnosisMuscle & Nerve, 2009
- Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia?Metabolism, 2009
- Asymptomatic Becker muscular dystrophy in a family with a multiexon deletionMuscle & Nerve, 2008
- Muscle Biopsy and In Vitro Contracture Test in Subjects with Idiopathic HyperCKemiaAnesthesiology, 2008
- Distribution of creatine kinase in the general population: Implications for statin therapyAmerican Heart Journal, 2007
- Frequency of calpain-3 c.550delA mutation in limb girdle muscular dystrophy type 2 and isolated hyperCKemia in German patientsClinical Neuropathology, 2007
- Familial idiopathic hyper‐CK‐emia: An underrecognized conditionMuscle & Nerve, 2006
- Muscle biopsy in the evaluation of patients with modestly elevated creatine kinase levelsMuscle & Nerve, 2002
- Malignant Hyperthermia Testing in Patients with Persistently Increased Serum Creatine Kinase LevelsAnesthesia & Analgesia, 1997
- Malignant Hyperthermia Testing in Patients with Persistently Increased Serum Creatine Kinase LevelsAnesthesia & Analgesia, 1997